Every trade that managers of 株式会社GENOVA disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector and is based in Tokyo, Japan. It was founded in 2005. 2 insiders have disclosed 4 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 3,425 companies tracked on its exchange, the median is 3 filings; at 4 filings, this issuer sits above that mark.
No insider has bought 株式会社GENOVA shares on the open market in the past twelve months. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Headquarters: Tokyo, Japan · Founded: 2005
Source: Wikidata (CC0).
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
23 of 23 declarations
GENOVA is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.
Purchases our model currently ranks for the recommendations list.
All recommendations